Foreign and domestic drugmakers oppose new rules for drug labeling in Russia

6 October 2016

All the drugs presenting on the Russian market will have to be labeled by a QR-code with the aim of preventing counterfeiting, according to recent statements of Denis Manturov, Russia’s Minister of Industry and Trade, reports The Pharma Letter’s local correspondent.

The government believes that QR-Code is cheap and does not affect the price of drugs. In addition, it will not result in a significant increase of costs for producers, it is claimed.

However, an official spokesman of the Russian Association of Pharmaceutical Manufacturers (RAPM), a trade association which unites both Russian and foreign drugmakers operating in the Russian market, has already criticized the latest state decision, believing that the introduction of the DataMatrix tag will be associated with lower costs for producers.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK